Vinnova is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G99). Contributions are tax-deductible.
1331 Nw Lovejoy Street, Portland, OR 97209-2799
Among the 21 scored disease & disorders organizations in Portland, Vinnova holds 0.1 months of operating reserves (peer median 8.1 months), runs a typical yearly surplus of 40.8% (peers: surplus of 5.0%), and has grown spending 14.3% a year (peers: grown spending 14.3% a year).
In fiscal year 2025 it reported $250,571 in revenue and $1,872,792 in expenses, with contributions making up 99.8% of revenue.
Promote and support education, research, and develoment of drugs related to disease conditions where the microcirculation is affected; solcit donations from individuals and entities in support of the activities of the corporation
Main program · fiscal year 2025
Promote and support education, research, and develoment of drugs related to disease conditions where the microcirculation is affected.$1,872,792 spent
Where each dollar went · fiscal year 2025
Of every dollar it spent, 100¢ went to programs, 0¢ to management and 0¢ to fundraising.
Programs $1,872,792
Management $0
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
100%
Meets
Compared with Portland peers
Measure
This organization
Peer median
Operating reserves
0.1 mo
8.1 mo
Typical margin
+40.8%
+5.0%
Spending growth
+14.3% / yr
+14.3% / yr
Debt load
0.0%
3.7%
Peers: the 21 Portland disease & disorders organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$250,571Fiscal year 2025
Expenses$1,872,792Fiscal year 2025
Total assets$22,279Fiscal year 2025
Total liabilities$0Fiscal year 2025
Fiscal year ending December2025
Revenue$250,571
Expenses$1,872,792
Net income−$1,622,221
Net assets$22,279
Notable sources of revenue
Percent of total revenue
Contributions
$250,000
99.8%
Program services
$0
0.0%
Investment income
$571
0.2%
Other (net)
$0
0.0%
Assets / debt
Total assets
$22,279
Total liabilities
$0
Net assets
$22,279
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$4,394,177
Expenses$1,638,745
Net income$2,755,432
Net assets$1,644,500
Notable sources of revenue
Percent of total revenue
Contributions
$2,911,160
66.3%
Program services
$0
0.0%
Investment income
$1,483,017
33.7%
Other (net)
$0
0.0%
Assets / debt
Total assets
$1,644,500
Total liabilities
$0
Net assets
$1,644,500
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$63,104
Expenses$1,688
Net income$61,416
Net assets$186,034
Notable sources of revenue
Percent of total revenue
Contributions
$57,313
90.8%
Program services
$0
0.0%
Investment income
$5,688
9.0%
Other (net)
$103
0.2%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$186,034
Compensation
Not in our extract for this year.
Fiscal year ending December2022
Revenue$1,535
Expenses$3,504
Net income−$1,969
Net assets$0
Notable sources of revenue
Percent of total revenue
Contributions
$0
0.0%
Program services
$0
0.0%
Investment income
$1,535
100.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$1
Total liabilities
$0
Net assets
$0
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?